Recent News:
Jun 24, 2009
Ash Access Technology's PMA for ZuragenŽ Solution Accepted for Filing by FDA
Aug 22, 2008
Ash Access Technology Completes AZEPTIC Trial for ZuragenŽ Injection
Feb 11, 2008
Dr. Stephen Ash Receives Lifetime Acheivement Award
|
Ash Access Technology, Inc. is an integrated
specialty pharmaceutical / medical device company engaged in the
development and commercialization of proprietary technologies and
devices to treat and prevent the clinical consequences of diseases
and disorders related to vascular access. The company has an advanced
portfolio of innovative products targeting catheter-related bloodstream
infections (CRBSI) and poor patency (blood flow) – the significant
challenges associated with the use of both acute and chronic catheters
for vascular access. more...
|